Delivery Order SPE2DB24D2018-SPE2DB25FWWV8
Award Date 9/18/25
Potential Completion Date 9/19/25
Potential Value $39K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $34,841.13 on May 30, 2025, for the supply of Multaq 400 mg tablets (60-count units) to support federal medical procurement needs. This firm fixed-price, competitively awarded contract (no set-aside designation) is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 2, 2025. The delivery order is funded through the Defense Medical Supply Chain, a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $1,025.26. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $20,853.40 for 60 tablets of Multaq 400 mg on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside contract utilizes firm fixed price terms and represents a single delivery order under a larger indefinite delivery contract vehicle. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office operates as...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $39,232.30 by the Defense Logistics Agency (DLA) for the supply of Multaq 400 mg tablets (60-count units). This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by July 31, 2025. The award was issued on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a continuation of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 7, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $28,708.59. This firm fixed-price contract, issued through the Defense Logistics Agency's Medical Supply Chain, represents a competitive award with no set-aside designation. The ultimate completion date is set for August 8, 2025, with performance occurring at...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $8,120.96. This firm fixed-price delivery order, which must be completed by August 20, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 6, 2025, for $5,578.34 to supply 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiovascular treatment. This is a firm fixed price, non-competitive delivery order executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The product will be delivered to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for Multaq 400 mg tablets (60-count units) valued at $4,589.64. The contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a competitively awarded transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $6,351.04 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $11,497.10 firm fixed price delivery order by the Defense Department's Medical Supply Chain on September 12, 2025, for 60 tablets of Multaq 400mg. The award was made competitively with no set-aside designation and has an ultimate completion date of October 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the...